Expert Pitch
Arizona State University (ASU)

Why ratification of USMCA trade deal is important

The ratification of the trade deal is important for several reasons:  

  • First, an update to NAFTA is needed because the world has changed so much since the original agreement went into effect in 1994.  For example, NAFTA has almost no mention of computers or of the Internet, which makes sense given that it was negotiated in the early 1990s, but these things are clearly central to our lives today.  One of the key improvements of USMCA is its e-commerce chapter, which creates rules for digital trade and is also likely to serve as a template for similar chapters in future trade agreements.  More generally, US trade agreements have evolved since NAFTA, and so bringing it into line with current norms was necessary.
  • Second, the ratification of USMCA will eliminate a lot of the uncertainty that has been in the air throughout this process.  While it was always a longshot that the US would leave NAFTA without a replacement deal, there remained a lot of uncertainty about NAFTA's future and about the timeline for USMCA.  Now US companies that trade intensively with Mexico or Canada, or that have subsidiaries in these countries can rest more easily, knowing that USMCA will probably go into force soon.  
  • While USMCA helps to reduce uncertainty, it also adds two changes to NAFTA that may make investors nervous: (1) A sunset clause will require the three governments to renew the deal periodically, which leaves open the possibility that it will become endangered once again in the future; (2) the new agreement has eliminated most of the investment dispute courts that protect foreign investors from policies in host countries that threaten their investment returns.  Whether these are good or bad additions to the deal are open to discussion, but they are both create some risks for US-based foreign investors operating in Mexico and Canada.
  • Fourth, Democrats and labor organizations in the US had been critical of the earlier draft of USMCA, on the basis that it did not have sufficiently strong rules for labor and the environment.  They seem to have made progress in updating the agreement, as the new version of USMCA has mechanisms to monitor and enforce labor rights and environmental rules.  AFL-CIO plans to back the agreement, which suggests that these revisions are quite strong.

It is also important to mention that USMCA still must be ratified by the US Senate and by the Canadian legislature (Mexico was the first to ratify).  These ratifications are likely to happen in 2020.

 

Jonas Gamso’s research is on issues of global political economy, international development, and quantitative methods. He specializes in international trade with an emphasis on the western hemisphere. His primary research focus is on trade between developing countries, and the impacts of this sort of trade for sustainable development and governance.

As an assistant professor of international trade and global studies at Thunderbird School of Global Management in Arizona, Professor Gamso has published work on USMCA, the illegal ivory trade, foreign aid and on political risks to foreign investors, among other topics. A headshot and links to articles can be found in his expert profile:

https://newsroom.asu.edu/expert/jonas-gamso

Professor Gamso has access to a broadcast TV facility for live or taped interviews. Please contact him directly for availability.

 




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.10537